PSMD4 Antibodies

Santa Cruz Biotechnology features a diverse variety of PSMD4 monoclonal antibodies for advanced research in protein regulation and cellular processes. PSMD4 monoclonal antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PSMD4, also known as the 26S proteasome non-ATPase regulatory subunit 4, plays a critical role in the ubiquitin-proteasome pathway, which is essential for protein degradation and regulation of cellular homeostasis. By modulating the activity of the proteasome, PSMD4 influences various cellular processes, including cell cycle progression, apoptosis, and response to stress. Understanding PSMD4 function is crucial for elucidating mechanisms underlying numerous diseases, including cancer and neurodegenerative disorders. Researchers can explore protein degradation pathways through detailed analysis of PSMD4 activity and its interactions with other cellular components. Advanced imaging techniques combined with PSMD4 monoclonal antibodies enable visualization of protein localization and trafficking within cells. Investigating PSMD4's role in disease progression may reveal new therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for PSMD4 support researchers worldwide in advancing our understanding of fundamental cellular processes and disease mechanisms.